- Home
- GUT vs FBIOP Comparison
GUT vs FBIOP Comparison
Compare GUT & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GUT
- FBIOP
- Stock Information
- Founded
- GUT 1999
- FBIOP N/A
- Country
- GUT United States
- FBIOP United States
- Employees
- GUT N/A
- FBIOP 101
- Industry
- GUT Trusts Except Educational Religious and Charitable
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- GUT Finance
- FBIOP Health Care
- Exchange
- GUT Nasdaq
- FBIOP Nasdaq
- Market Cap
- GUT N/A
- FBIOP N/A
- IPO Year
- GUT N/A
- FBIOP N/A
- Fundamental
- Price
- GUT $5.30
- FBIOP $6.70
- Analyst Decision
- GUT
- FBIOP
- Analyst Count
- GUT 0
- FBIOP 0
- Target Price
- GUT N/A
- FBIOP N/A
- AVG Volume (30 Days)
- GUT 176.3K
- FBIOP N/A
- Earning Date
- GUT 01-01-0001
- FBIOP N/A
- Dividend Yield
- GUT 10.93%
- FBIOP N/A
- EPS Growth
- GUT N/A
- FBIOP N/A
- EPS
- GUT N/A
- FBIOP N/A
- Revenue
- GUT N/A
- FBIOP N/A
- Revenue This Year
- GUT N/A
- FBIOP N/A
- Revenue Next Year
- GUT N/A
- FBIOP N/A
- P/E Ratio
- GUT N/A
- FBIOP N/A
- Revenue Growth
- GUT N/A
- FBIOP N/A
- 52 Week Low
- GUT $4.60
- FBIOP N/A
- 52 Week High
- GUT $7.38
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- GUT 51.92
- FBIOP 66.72
- Support Level
- GUT $5.13
- FBIOP $6.00
- Resistance Level
- GUT $5.36
- FBIOP $6.80
- Average True Range (ATR)
- GUT 0.15
- FBIOP 0.41
- MACD
- GUT 0.01
- FBIOP 0.18
- Stochastic Oscillator
- GUT 83.10
- FBIOP 90.00
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.